Skip to content

Study · Non-randomized trial · n = 9 · 1991

2 results

Nasal administration of salmon calcitonin for prevention of glucocorticoid-induced osteoporosis in children with nephrosis.

Nishioka T, Kurayama H, Yasuda T, Udagawa J, Matsumura C, Niimi H

The Journal of pediatrics1 May 1991Cited by 22 (Europe PMC)

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study2

2 results from studies that gave the peptide. 2 results from people.

  1. 01HumanNon-randomized trialEfficacy outcome

    In children with nephrosis, added salmon calcitonin preserved cortical vertebral mineral content, while the vitamin D3-only control group lost mineral content significantly.

    In plain wordsIn children with nephrosis, added salmon calcitonin preserved cortical vertebral mineral content compared with vitamin D3 alone.

    Outcome
    IncreaseCortical vertebral bone mineral content
    Study

    n = 9

    Comparator
    1 alpha-hydroxyvitamin D3 alone
    Outcome group
    Bone and joint · Musculoskeletal
    Studied dose
    100 U on alternate days · intranasal · 16 monthsAs given in this study (human).

    Source sentences

    Summary
    The bone mineral content was preserved in both cortical and spongeous areas of the vertebrae during the 16-month period in the calcitonin-treated group but was decreased significantly in the control group.
    2 context sentences
    Summary · context
    To determine the effect of intranasal administration of salmon calcitonin on glucocorticoid-induced osteoporosis in children with nephrosis, we gave 100 U of calcitonin intranasally on alternate days with 1 alpha-hydroxyvitamin D3 to five children, 8 to 12 years of age, with frequently relapsing nephrosis.
    Summary · context
    Four patients with osteoporosis, 10 to 14 years of age, were treated only with 1 alpha-hydroxyvitamin D3 and served as control subjects.
  2. 02HumanNon-randomized trialEfficacy outcome

    In children with nephrosis, added salmon calcitonin preserved spongeous vertebral mineral content, while the vitamin D3-only control group lost mineral content significantly.

    In plain wordsIn children with nephrosis, added salmon calcitonin preserved spongeous vertebral mineral content compared with vitamin D3 alone.

    Outcome
    IncreaseSpongeous vertebral bone mineral content
    Study

    n = 9

    Comparator
    1 alpha-hydroxyvitamin D3 alone
    Outcome group
    Bone and joint · Musculoskeletal
    Studied dose
    100 U on alternate days · intranasal · 16 monthsAs given in this study (human).

    Source sentences

    Summary
    The bone mineral content was preserved in both cortical and spongeous areas of the vertebrae during the 16-month period in the calcitonin-treated group but was decreased significantly in the control group.
    2 context sentences
    Summary · context
    To determine the effect of intranasal administration of salmon calcitonin on glucocorticoid-induced osteoporosis in children with nephrosis, we gave 100 U of calcitonin intranasally on alternate days with 1 alpha-hydroxyvitamin D3 to five children, 8 to 12 years of age, with frequently relapsing nephrosis.
    Summary · context
    Four patients with osteoporosis, 10 to 14 years of age, were treated only with 1 alpha-hydroxyvitamin D3 and served as control subjects.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    28 Oct 2026, 02:03 UTC

    Study results updated

  2. Version 1

    27 Oct 2026, 16:35 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.